Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.

Authors
Dequen, P
Lorigan, Paul C
Jansen, J
van Baardewijk, M
Ouwens, M
Kotapati, S
Affiliation
MAPI Group, Houten, The Netherlands.
Issue Date
2012

Metadata
Show full item record
Abstract
To compare the overall survival (OS) of patients treated with 3 mg/kg ipilimumab versus alternative systemic therapies in pretreated unresectable stage III or IV melanoma patients.
Citation
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg Ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. 2012, 17 (11):1376-85 Oncologist
Journal
The Oncologist
URI
http://hdl.handle.net/10541/275684
DOI
10.1634/theoncologist.2011-0427
PubMed ID
23024154
Type
Article
Language
en
ISSN
1549-490X
Collections